One of the better articles we've seen lately comes from USA Today, explaining what is likely to happ...
In the latest article about the apparent end of the semaglutide shortage, the Advisory Board (which ...
The Reuters story, “Novo's Wegovy and Ozempic removed from US FDA shortage list, compounders on noti...
Stat News covered the fact that “Dozens of attorneys general urge FDA to crack down on counterfeit o...
NPR’s Sydney Lupkin took another angle on the GLP-1 story: What happens when patients use an unlicen...
NPR station WHYY was one of many that covered the Hims & Hers Super Bowl ad, and one of many that tu...
Seeking Alpha, which focuses on financial news, took a look at Hims & Hers, and couldn’t help but me...
In the run-up to the Super Bowl, APC spent considerable time correcting misinformation about whether...
As the Outsourcing Facilities Association goes ahead with its lawsuit against the FDA over the agenc...
NPR ran an updated story on the ‘battle’ between compounders and drug makers over GLP-1 weight-loss ...